Bacterial Skin Infection
📧 Sign up to get email alerts when something new happens for Bacterial Skin Infection.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-20EMA Authorised: Daptomycin Hospira (daptomycin) — Pfizer Europe MA EEIG
The EMA authorised Daptomycin Hospira (daptomycin) for marketing in the EU for soft tissue infections and bacterial skin infections, with de…
-
FDA approval · 2025-11-10FDA Approved: CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved a generic topical product containing ciprofloxacin hydrochloride and hydrocortisone under an original application for Cosette P…
-
FDA approval · 2025-05-13FDA Approved: MUPIROCIN — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals, Inc.'s original application for mupirocin topical antibiotic (generic mupirocin).
-
EMA approval · 2024-11-20EMA Authorised: Tenkasi (previously Orbactiv) (oritavancin (diphosphate)) — Menarini International Operations Luxembourg S.A.
The European Medicines Agency has authorised Tenkasi (oritavancin diphosphate) by Menarini International Operations Luxembourg S.A. for soft…
-
FDA approval · 2024-07-08FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Mupirocin by Glenmark Pharmaceuticals Inc., USA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-08-04FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for mupirocin.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)
Post-marketing surveillance trial for ALTARGO (retapamulin) has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004) [Phase 1]
A Phase 1 study to evaluate the pharmacokinetics and safety of potential drug interactions between tedizolid phosphate and the drugs midazol…
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age [Phase 2]
Phase 2 pediatric study evaluating the pharmacokinetics, safety, and tolerability of tigecycline in children aged 8 to 11 years has complete…
-
CLINICAL_TRIALS trial_result · 2010-04-30Clinical Trial Update: Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. [Phase 4]
Phase 4 trial evaluating the pharmacokinetics of retapamulin in pediatric patients with uncomplicated bacterial skin infections; results hav…